Terry J Smith Selected Research

gadolinium-IGG complex

9/2008	Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease.
10/2004	Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terry J Smith Research Topics

Disease

72	Graves Ophthalmopathy 01/2022 - 03/2002
60	Graves Disease (Basedow Disease) 12/2021 - 01/2002
14	Inflammation (Inflammations) 01/2022 - 06/2003
13	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 09/2004
10	Hyperthyroidism 01/2018 - 12/2003
9	Exophthalmos (Proptosis) 01/2022 - 01/2005
7	Neuromyelitis Optica (Devic's Disease) 01/2022 - 07/2015
4	Hyperglycemia 01/2022 - 01/2017
4	Diplopia (Double Vision) 01/2022 - 01/2020
4	Optic Nerve Diseases (Optic Neuropathy) 12/2021 - 06/2012
4	Neoplasms (Cancer) 01/2019 - 01/2006
4	Fibrosis (Cirrhosis) 10/2016 - 03/2005
3	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2015
3	Bacterial Meningitis 01/2020 - 01/2018
3	Thyroid Diseases (Thyroid Disease) 01/2007 - 01/2002
2	Optic Neuritis (Retrobulbar Neuritis) 01/2022 - 01/2022
2	Communicable Diseases (Infectious Diseases) 06/2021 - 01/2018
2	Carcinogenesis 01/2021 - 01/2006
2	Body Weight (Weight, Body) 01/2021 - 01/2020
2	Disease Progression 01/2021 - 06/2012
2	Hearing Loss (Hearing Impairment) 01/2021 - 01/2021
2	Infections 01/2020 - 10/2016
2	Pheochromocytoma 01/2012 - 03/2010
2	Necrosis 01/2009 - 01/2002
2	Pre-Eclampsia (Preeclampsia) 01/2008 - 07/2006
2	Goiter 01/2007 - 07/2003
1	Atrophy 01/2022
1	Ganglion Cysts (Ganglion) 01/2022
1	COVID-19 06/2021
1	Hashimoto's encephalitis 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Confusion (Bewilderment) 01/2021
1	Acromegaly 01/2021
1	Spasm (Spasms) 01/2021
1	Muscle Cramp (Cramp) 07/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Rare Diseases (Rare Disease) 01/2019
1	Essential Thrombocythemia 08/2017
1	Primary Myelofibrosis (Myelosclerosis) 08/2017

Drug/Important Bio-Agent (IBA)

47	Troleandomycin (TAO)FDA Link 01/2022 - 03/2002
18	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2022 - 12/2003
15	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2022 - 06/2003
14	teprotumumabIBA 01/2022 - 01/2017
13	AntibodiesIBA 12/2021 - 12/2003
12	CytokinesIBA 01/2021 - 03/2002
8	Immunoglobulin G (IgG)IBA 01/2022 - 09/2004
8	AutoantigensIBA 01/2019 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2003
7	Hyaluronic Acid (Hyaluronan)IBA 01/2022 - 03/2002
7	Insulin (Novolin)FDA Link 01/2016 - 09/2003
6	AntigensIBA 12/2021 - 09/2008
6	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018 - 04/2006
6	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2005
6	AutoantibodiesIBA 06/2015 - 04/2006
4	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022 - 10/2004
4	Pharmaceutical PreparationsIBA 07/2020 - 06/2010
4	GlycosaminoglycansIBA 07/2011 - 03/2002
4	Chemotactic FactorsIBA 09/2008 - 01/2002
3	Retinaldehyde (Retinal)IBA 01/2022 - 10/2020
3	Nucleic AcidsIBA 06/2021 - 01/2018
3	Monoclonal AntibodiesIBA 07/2020 - 06/2010
3	RNA (Ribonucleic Acid)IBA 04/2020 - 01/2015
3	MicroRNAs (MicroRNA)IBA 04/2020 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2012
3	Rituximab (Mabthera)FDA Link 07/2014 - 01/2010
3	Dinoprostone (PGE2)FDA Link 12/2010 - 01/2006
3	Messenger RNA (mRNA)IBA 04/2009 - 07/2006
3	Chemokine CCL5IBA 04/2006 - 01/2002
2	Biological ProductsIBA 11/2019 - 09/2008
2	tetraiodothyroacetic acid (TA(4))IBA 01/2019 - 01/2017
2	CollagenIBA 01/2019 - 01/2009
2	Thyroid-Stimulating ImmunoglobulinsIBA 01/2017 - 09/2011
2	CD40 Ligand (CD40L)IBA 12/2016 - 11/2012
2	LigandsIBA 10/2016 - 11/2012
2	ChemokinesIBA 10/2016 - 05/2012
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2014 - 06/2003
2	Interleukin-1 (Interleukin 1)IBA 04/2014 - 06/2003
2	2-mercaptoacetate (ammonium thioglycolate)IBA 01/2012 - 03/2010
2	Thrombin FDA Link 01/2009 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009 - 01/2002
2	gadolinium-IGG complexIBA 09/2008 - 10/2004
2	Interleukin-16 (Interleukin 16)IBA 04/2006 - 09/2004
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2006 - 07/2005
2	Immunoglobulins (Immunoglobulin)IBA 10/2004 - 06/2003
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2020
1	Phenobarbital (Luminal)FDA Link 04/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	GlucocorticoidsIBA 11/2019
1	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2019
1	Thyroglobulin FDA Link 01/2019
1	EnzymesIBA 01/2019
1	Deoxyribonuclease IV (Phage T4-Induced)IBA 01/2018
1	EndonucleasesIBA 01/2018
1	Recombinases (Recombinase)IBA 01/2018
1	CalreticulinIBA 08/2017

Therapy/Procedure

17	Therapeutics 12/2021 - 09/2008
2	Intravenous Infusions 01/2021 - 01/2020
1	Retreatment 01/2021